Page last updated: 2024-10-15

alpha-hydroxyglutarate and Bile Duct Obstruction

alpha-hydroxyglutarate has been researched along with Bile Duct Obstruction in 1 studies

2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tian, X3
Wang, Y3
Lu, Y3
Wu, B3
Chen, S3
Du, J3
Cai, W3
Xiao, Y3

Other Studies

1 other study available for alpha-hydroxyglutarate and Bile Duct Obstruction

ArticleYear
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
    Cell death & disease, 2022, 11-26, Volume: 13, Issue:11

    Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases

2022